Type 2 & other diabetes

Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)

Diabetes CarePublished Secondary analysis of the DPP/DPPOS randomised trial and follow-up cohort

Authors' conclusion

Twenty-year retention of a racially and geographically diverse cohort with prediabetes is possible. Retention was associated with age, psychosocial factors, T2D development, and BMI.

Study context

Population
Adults at high risk of T2D (prediabetes) in the DPP (1996–1999, mean age 51 ± 10 years), randomized to lifestyle, metformin or placebo and followed through 2020 in DPPOS3,218 surviving
Participants
3,234 adults
Primary endpoint
Study retention: short-term retention and time to dropout
Follow-up
∼3 years; 20 years
Methodological detailslongitudinal, 20-year follow-up, logistic regression, Cox proportional hazards models, censoring at death
  • Longitudinal
  • 20-year follow-up
  • Logistic regression
  • Cox proportional hazards models, censoring at death

Primary result

As reported in the abstract

Retention
Retained after 3 years among surviving participants
93%
Surviving participants remaining engaged over 20 years
75%
Better health state (SF-36), HR for dropout per 0.1 point
0.89 (95% CI 0.83-0.95)
Greater BMI, HR per 5 kg/m² (reduced retention)
1.06 (95% CI 1.00-1.12)
More recent life events, HR (reduced retention)
1.08 (95% CI 1.02-1.14)
Depressive symptoms, HR per 5 points (reduced retention)
1.11 (95% CI 1.05-1.18)

Further findings

Retention by T2D development, adults 45-59 years at baseline

Development of T2D associated with better retention, HR
0.75 (95% CI 0.58-0.97)

Original publication

Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS). Diabetes Care. Published 20 June 2025. doi:10.2337/dc25-0520

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.